Skip to main content
Journal cover image

Staging non-small cell lung cancer with whole-body PET.

Publication ,  Journal Article
Marom, EM; McAdams, HP; Erasmus, JJ; Goodman, PC; Culhane, DK; Coleman, RE; Herndon, JE; Patz, EF
Published in: Radiology
September 1999

PURPOSE: To compare the accuracies of whole-body 2-[fluorine 18]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) and conventional imaging (thoracic computed tomography [CT], bone scintigraphy, and brain CT or magnetic resonance [MR] imaging) in staging bronchogenic carcinoma. MATERIALS AND METHODS: Within 20 months, 100 patients with newly diagnosed bronchogenic carcinoma underwent whole-body FDG PET and chest CT. Ninety of these patients underwent radionuclide bone scintigraphy, and 70 patients underwent brain CT or MR imaging. For each patient, all examinations were completed within 1 month. A radiologic stage was assigned by using PET and conventional imaging independently and was compared with the pathologic stage. The accuracy, sensitivity, specificity, and negative and positive predictive values were calculated. RESULTS: PET staging was accurate in 83 (83%) patients; conventional imaging staging was accurate in 65 (65%) patients (P < .005). Staging with mediastinal lymph nodes was correct by using PET in 67 (85%) patients and by using CT in 46 (58%) patients (P < .001). Nine (9%) patients had metastases demonstrated by using PET that were not found with conventional imaging, whereas 10 (10%) patients suspected of having metastases because of conventional imaging findings were correctly shown with PET to not have metastases. CONCLUSION: Whole-body PET was more accurate than thoracic CT, bone scintigraphy, and brain CT or MR imaging in staging bronchogenic carcinoma.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Radiology

DOI

ISSN

0033-8419

Publication Date

September 1999

Volume

212

Issue

3

Start / End Page

803 / 809

Location

United States

Related Subject Headings

  • Whole-Body Counting
  • Tomography, X-Ray Computed
  • Tomography, Emission-Computed
  • Sensitivity and Specificity
  • Nuclear Medicine & Medical Imaging
  • Neoplasm Staging
  • Middle Aged
  • Male
  • Magnetic Resonance Imaging
  • Lymphatic Metastasis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Marom, E. M., McAdams, H. P., Erasmus, J. J., Goodman, P. C., Culhane, D. K., Coleman, R. E., … Patz, E. F. (1999). Staging non-small cell lung cancer with whole-body PET. Radiology, 212(3), 803–809. https://doi.org/10.1148/radiology.212.3.r99se21803
Marom, E. M., H. P. McAdams, J. J. Erasmus, P. C. Goodman, D. K. Culhane, R. E. Coleman, J. E. Herndon, and E. F. Patz. “Staging non-small cell lung cancer with whole-body PET.Radiology 212, no. 3 (September 1999): 803–9. https://doi.org/10.1148/radiology.212.3.r99se21803.
Marom EM, McAdams HP, Erasmus JJ, Goodman PC, Culhane DK, Coleman RE, et al. Staging non-small cell lung cancer with whole-body PET. Radiology. 1999 Sep;212(3):803–9.
Marom, E. M., et al. “Staging non-small cell lung cancer with whole-body PET.Radiology, vol. 212, no. 3, Sept. 1999, pp. 803–09. Pubmed, doi:10.1148/radiology.212.3.r99se21803.
Marom EM, McAdams HP, Erasmus JJ, Goodman PC, Culhane DK, Coleman RE, Herndon JE, Patz EF. Staging non-small cell lung cancer with whole-body PET. Radiology. 1999 Sep;212(3):803–809.
Journal cover image

Published In

Radiology

DOI

ISSN

0033-8419

Publication Date

September 1999

Volume

212

Issue

3

Start / End Page

803 / 809

Location

United States

Related Subject Headings

  • Whole-Body Counting
  • Tomography, X-Ray Computed
  • Tomography, Emission-Computed
  • Sensitivity and Specificity
  • Nuclear Medicine & Medical Imaging
  • Neoplasm Staging
  • Middle Aged
  • Male
  • Magnetic Resonance Imaging
  • Lymphatic Metastasis